Botanix Pharmaceuticals

(ASX) BOT

Current PriceA$0.02

Market CapA$62.89M

Since IPO (2016)-30%

5 Year-67%

1 Year-93%

1 Month-23%

Botanix Pharmaceuticals Financials at a Glance

Market Cap

A$62.89M

Revenue (TTM)

A$23.99M

Net Income (TTM)

-A$127.99M

EPS (TTM)

-A$0.05

P/E Ratio

-0.49

Dividend

A$0.00

Beta (Volatility)

0.05 (Low)

Dividend

A$0.00

Beta (Volatility)

0.05 (Low)

Price

A$0.02

Volume

8,280,767

Open

A$0.02

Price

A$0.02

Volume

8,280,767

Open

A$0.02

Previous Close

A$0.02

Daily Range

A$0.02 - A$0.02

52-Week Range

A$0.02 - A$0.35

Estimated Earnings Date

Aug 28, 2026

Dividend

A$0.00

Beta (Volatility)

0.05 (Low)

Price

A$0.02

Volume

8,280,767

Open

A$0.02

Previous Close

A$0.02

Daily Range

A$0.02 - A$0.02

52-Week Range

A$0.02 - A$0.35

Estimated Earnings Date

Aug 28, 2026

BOT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Botanix Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

CEO

Howie McKibbon, PharmD

Website

www.botanixpharma.com

Headquarters

Leederville, WA 6007, AU

BOT Financials

Key Financial Metrics (TTM)

Gross Margin

-1%

Operating Margin

-4%

Net Income Margin

-4%

Return on Equity

-121%

Return on Capital

-1%

Return on Assets

-90%

Earnings Yield

-2.04%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$62.89M

Shares Outstanding

2.73B

Volume

8.28M

Avg. Volume

22.73M

Financials (TTM)

Gross Profit

A$2.02M

Operating Income

-A$80.79M

EBITDA

-A$80.65M

Operating Cash Flow

-A$78.58M

Capital Expenditure

-A$286.43K

Free Cash Flow

-A$78.87M

Cash & ST Invst.

A$64.97M

Total Debt

A$32.51M

Botanix Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$16.51M

+4267.4%

Gross Profit

-A$28.76M

-850.8%

Gross Margin

-1.74%

N/A

Market Cap

A$62.89M

N/A

Market Cap/Employee

A$5.72M

N/A

Employees

N/A

Net Income

-A$33.20M

-507.2%

EBITDA

-A$32.43M

-487.8%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$31.61M

+72.6%

Total Debt

A$30.67M

N/A

Accounts Receivable

A$5.70M

+2497.1%

Inventory

A$27.51M

+778.3%

Long Term Debt

A$17.54M

N/A

Short Term Debt

A$13.13M

N/A

Return on Assets

-89.99%

N/A

Return on Invested Capital

-1.18%

N/A

Free Cash Flow

-A$32.64M

-76.1%

Operating Cash Flow

-A$32.64M

-768.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PAR.AXParadigm Biopharmaceuticals Limited

PAR.AXParadigm Biopharmaceuticals LimitedA$0.15+3.45%

NYR.AXNyrada Inc.

NYR.AXNyrada Inc.A$0.44-2.22%

DXB.AXDimerix Limited

DXB.AXDimerix LimitedA$0.17-2.94%

ATH.AXAlterity Therapeutics Limited

ATH.AXAlterity Therapeutics LimitedA$0.50+11.24%

ACW.AXActinogen Medical Limited

ACW.AXActinogen Medical LimitedA$0.03+0.00%

RCE.AXRecce Pharmaceuticals Ltd

RCE.AXRecce Pharmaceuticals LtdA$0.50+2.04%

OCC.AXOrthocell Limited

OCC.AXOrthocell LimitedA$0.74-1.34%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

RKLBRocket Lab

RKLBRocket Lab$102.39-0.11%

Questions About BOT

What is the current price of Botanix Pharmaceuticals?

Botanix Pharmaceuticals is trading at A$0.02 per share.

What is the 52-week range for Botanix Pharmaceuticals?

Over the past 52 weeks, Botanix Pharmaceuticals has traded between A$0.02 and A$0.35.

How much debt does Botanix Pharmaceuticals have?

As of the most recent reporting period, Botanix Pharmaceuticals reported total debt of A$32.11M.

How much cash does Botanix Pharmaceuticals have on hand?

Botanix Pharmaceuticals reported A$64.97M in cash and cash equivalents in its most recent financial results.

What is Botanix Pharmaceuticals’s dividend yield?

Botanix Pharmaceuticals does not currently have a dividend yield.

Botanix Pharmaceuticals

Botanix Pharmaceuticals Financials at a Glance

BOT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Botanix Pharmaceuticals

BOT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Botanix Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BOT

What is the current price of Botanix Pharmaceuticals?

What is the 52-week range for Botanix Pharmaceuticals?

How much debt does Botanix Pharmaceuticals have?

How much cash does Botanix Pharmaceuticals have on hand?

What is Botanix Pharmaceuticals’s dividend yield?

Premium Investing Services